TITLE

Pills in the Pipeline

AUTHOR(S)
Park, Alice
PUB. DATE
June 2004
SOURCE
Time;6/7/2004, Vol. 163 Issue 23, p90
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Discusses the possibility that drugs will be developed to fight obesity. Consideration of how the feeding mechanism is a survival mechanism that is different in every person; How researchers at GlaxoSmithKline are studying how the chemical cholecystokinin is released by the intestines after a meal to signal the brain that the body has eaten enough food; Research on how the agent Axokine fools the brain into thinking that the body's fat stores are full by scientists at Regeneron; Focus on therapies that aim to stop the development of fat tissue in the human body.
ACCESSION #
13241539

 

Related Articles

  • Does birth weight predict childhood obesity? Persons, Robert K.; Sevdy, Tristan L.; Nichols, William // Journal of Family Practice;Jun2008, Vol. 57 Issue 6, p409 

    The article reports on the study regarding the significance of birth weight in predicting childhood obesity in the U.S. Because of the prevalence of childhood obesity, scientists and researchers are looking for ways to determine the causes and treatment of obesity. They discovered that birth...

  • Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Shi, Yuguang; Burn, Paul // Nature Reviews Drug Discovery;Aug2004, Vol. 3 Issue 8, p695 

    Obesity is a complex disease that is regulated by both central and peripheral mechanisms. New medicines for the treatment and prevention of obesity will need to overcome the powerful compensatory responses of the overlapping, and often redundant, networks that have evolved to safeguard efficient...

  • Susceptibility Loci for Adiposity Phenotypes on 8p, 9p, and 16q in American Samoa and Samoa. Åberg, Karolina; Feng Dai; Guangyun Sun; Keighley, Ember D.; Indugula, Subba R.; Roberts, Sarah T.; Qi Zhang; Smelser, Diane; Viali, Satupaitea; Tuitele, John; Li Jin; Deka, Ranjan; Weeks, Daniel E.; McGarvey, Stephen T. // Obesity (19307381);Mar2009, Vol. 17 Issue 3, p518 

    Obesity is a complex phenotype affected by genetic and environmental influences such as sociocultural factors and individual behaviors. Previously, we performed two separate genome-wide investigations for adiposity-related traits (BMI, percentage body fat (%BF), abdominal circumference (ABDCIR),...

  • Prevalencia de Obesidad y Factores de Riesgo para Desarrollar Patologías Asociadas. de García, Doris García; Alfaro, Arabel del Carmen // Crea Ciencia;dic2006, Vol. 3 Issue 5, p22 

    Obesity is an excessive accumulation of fat in the body's fatty tissues that can end up constituting a serious health problem. It is also defined, as a chronic multicause etiology illness. The objective of the study was to determine the prevalence of obesity and the factors of risk to develop...

  • Obesity is a large topic. Veal, Kath // Food Manufacture;Jan2007, Vol. 82 Issue 1, p19 

    The article presents obesity as one of the major health problems not only in Great Britain but globally. With the food promotions and weight loss marketing, departments must ensure they are on top of transition periods for the European Commission Regulation on Nutrition and Health Claims. In...

  • Office-Based Strategies for the Management of Obesity. RAO, GOUTHAM // American Family Physician;6/15/2010, Vol. 81 Issue 12, p1449 

    Roughly two thirds of U.S. adults are overweight or obese. Obesity increases the risk of hypertension, type 2 diabetes mellitus, hyperlipidemia, heart disease, pulmonary disease, hepatobiliary disease, cancer, and a number of psychosocial complications. Physicians often feel unprepared to handle...

  • Význam časné detekce inzulinové rezistence u dÄ›tské populace. Pastucha, Dalibor; Malinčíková, Jana; Hyjánek, Jiří; Horáková, Dagmar; Janout, Vladimír // Medicina Sportiva Bohemica et Slovaca;2008, Vol. 17 Issue 3, p145 

    Obesity and arterial hypertension are a serious risk factors for insulin resistance patients leading to diabetes and other disorders. The aim of this study was to compare average levels of the homeostatic indices HOMA and QUICKI in obese children compared to healthy and hypertonic children in...

  • Exercise in a Pill: Feasibility of Energy Expenditure Targets. Himms-Hagen, J. // Current Drug Targets - CNS & Neurological Disorders;Oct2004, Vol. 3 Issue 5, p389 

    The possibility of developing a pill to increase energy expenditure is explored by examining the metabolic processes involved. Such a pill should be targeted at organ systems involved in facultative thermogenesis. In rodents, these are brown adipose tissue (BAT) and skeletal muscle. Since...

  • Reversal of obesity by targeted ablation of adipose tissue. Kolonin, Mikhail G.; Saha, Pradip K.; Chan, Lawrence; Pasqualini, Renata; Arap, Wadih // Nature Medicine;Jun2004, Vol. 10 Issue 6, p625 

    Obesity is an increasingly prevalent human condition in developed societies. Despite major progress in the understanding of the molecular mechanisms leading to obesity, no safe and effective treatment has yet been found. Here, we report an antiobesity therapy based on targeted induction of...

Share

Read the Article

Other Topics